Limula SA is a start-up company based in Lausanne, Switzerland. We develop a cell processing platform technology to enable decentralised cell and gene therapy (CGT) production at scale. By bringing manufacturing closer to the patients, our solution will broaden access to highly personalized treatments. Combining the expertise of our multidisciplinary team and our unique patented tool, we want to support biotech companies with CGT assets, CDMO with CGT customers, and hospitals with CGT trials, at all stages of the life cycle of their therapies, from pre-clinical R&D to patient batch production.